Hetero's Tocira gets Emergency Use Authorization from DCGI for the generic version of Tocilizumab in India.
<p>
Hyderabad-based pharma company Hetero said on Monday it has received emergency use approval from the Indian health authorities to make a generic version of Swiss giant Roche Holding AG&#39;s drug Tocilizumab used for treating COVID-19 patients.</p>
<p>
Hetero is likely to make the cheaper version of Tocilizumab available in Indian market by the end of the month under the local brand name Tocira. The drug will be produced at the company&rsquo;s plant in Hyderabad.</p>
<p>
Tocilizumab has been in high demand due to the surge in COVID-19 cases and there is a shortage of the drug worldwide.</p>
<p>
Roche&#39;s blockbuster arthritis drug, tocilizumab, cuts the risk of death among patients hospitalised with severe COVID-19. It also cuts the recovery time and reduces the need for mechanical ventilation.</p>
<p>
Hetero, also makes medicines such as remdesivir and favipiravir used for treating COVID-19 patients.</p>
The India-UK Free Trade Agreement, signed by Prime Minister Narendra Modi and UK Prime Minister…
The Ministry of Health and Family Welfare has achieved a major milestone in women's health,…
Chief of Army Staff General Upendra Dwivedi on Saturday addressed the Kargil Vijay Diwas celebrations…
Chief of Defence Staff General Anil Chauhan on Saturday paid heartfelt tribute to the brave…
Israeli Prime Minister Benjamin Netanyahu on Friday said that Israel and the United States are…
Both Cambodia and Thailand have written to the United Nations Security Council (UNSC) following two…